AAAAAA

   
Results: 1-25 | 26-49 |
Results: 26-49/49
HIGH-DOSE (HD) CHEMOTHERAPY AND AUTOGRAFT WITH PERIPHERAL PROGENITORSAS FIRST-LINE TREATMENT IN MULTIPLE-MYELOMA - HIGH EFFICACY IN PATIENTS WITH HIGH PLASMA-CELL PROLIFERATIVE ACTIVITY
Authors: TARELLA C BOCCADORO M CORRADINI P CARACCIOLO D PALUMBO A ARGENTINO C LOMBARDI F BREGNI M SIENA S GIANNI AM PILERI A
Citation: C. Tarella et al., HIGH-DOSE (HD) CHEMOTHERAPY AND AUTOGRAFT WITH PERIPHERAL PROGENITORSAS FIRST-LINE TREATMENT IN MULTIPLE-MYELOMA - HIGH EFFICACY IN PATIENTS WITH HIGH PLASMA-CELL PROLIFERATIVE ACTIVITY, Blood, 86(10), 1995, pp. 3858-3858
A STANDARDIZED FLOW-CYTOMETRY PROTOCOL FOR MOBILIZED PERIPHERAL CD34(-PATIENTS() CELLS ESTIMATION AND COLLECTION FOR AUTOTRANSPLANTATION INCANCER)
Authors: BRANDO B SIENA S BREGNI M GIANNI AM GRILLO P SOMMARUGA E
Citation: B. Brando et al., A STANDARDIZED FLOW-CYTOMETRY PROTOCOL FOR MOBILIZED PERIPHERAL CD34(-PATIENTS() CELLS ESTIMATION AND COLLECTION FOR AUTOTRANSPLANTATION INCANCER), European journal of histochemistry, 38, 1994, pp. 21-26
CLINICAL UTILIZATION OF HUMAN HEMATOPOIETIC PROGENITORS ELICITED IN PERIPHERAL-BLOOD BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHUG-CSF)
Authors: BREGNI M SIENA S BONADONNA G GIANNI AM
Citation: M. Bregni et al., CLINICAL UTILIZATION OF HUMAN HEMATOPOIETIC PROGENITORS ELICITED IN PERIPHERAL-BLOOD BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHUG-CSF), European journal of cancer, 30A(2), 1994, pp. 235-238
DURABILITY OF HEMATOPOIESIS FOLLOWING AUTOGRAFTING WITH PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITORS
Authors: SIENA S BREGNI M DINICOLA M RAVAGNANI F PECCATORI F GANDOLA L LOMBARDI F TARELLA C BONADONNA G GIANNI AM
Citation: S. Siena et al., DURABILITY OF HEMATOPOIESIS FOLLOWING AUTOGRAFTING WITH PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITORS, Annals of oncology, 5(10), 1994, pp. 935-941
HIGH-DOSE SEQUENTIAL CHEMORADIOTHERAPY, A WIDELY APPLICABLE REGIMEN, CONFERS SURVIVAL BENEFIT TO PATIENTS WITH HIGH-RISK MULTIPLE-MYELOMA
Authors: GIANNI AM TARELLA C BREGNI M SIENA S LOMBARDI F GANDOLA L CARACCIOLO D STERN A BONADONNA G BOCCADORO M PILERI A
Citation: Am. Gianni et al., HIGH-DOSE SEQUENTIAL CHEMORADIOTHERAPY, A WIDELY APPLICABLE REGIMEN, CONFERS SURVIVAL BENEFIT TO PATIENTS WITH HIGH-RISK MULTIPLE-MYELOMA, Journal of clinical oncology, 12(3), 1994, pp. 503-509
PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS ARE PRESENT IN PERIPHERAL-BLOOD AUTOGRAFTS
Authors: TONG J GIANNI AM SIENA S SROUR EF BREGNI M HOFFMAN R
Citation: J. Tong et al., PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS ARE PRESENT IN PERIPHERAL-BLOOD AUTOGRAFTS, Blood cells, 20(2-3), 1994, pp. 351-363
LONG-TERM HEMATOPOIETIC CULTURE-INITIATING CELLS MOBILIZED INTO PERIPHERAL-BLOOD WITH HIGH-DOSE CYCLOPHOSPHAMIDE AND RECOMBINANT CYTOKINES DO NOT UNDERGO ADDITIONAL EX-VIVO EXPANSION
Authors: SROUR EF SIENA S BREGNI M KOSAK S TRAYCOFF CM GRIGSBY S GIANNI AM
Citation: Ef. Srour et al., LONG-TERM HEMATOPOIETIC CULTURE-INITIATING CELLS MOBILIZED INTO PERIPHERAL-BLOOD WITH HIGH-DOSE CYCLOPHOSPHAMIDE AND RECOMBINANT CYTOKINES DO NOT UNDERGO ADDITIONAL EX-VIVO EXPANSION, Experimental hematology, 22(8), 1994, pp. 784-784
UN3, A NOVEL MONOCLONAL-ANTIBODY TO HUMAN BONE-MARROW CD34+ HEMATOPOIETIC PROGENITORS
Authors: TASSONE P BONELLI P TUCCILLO F CECCO L CERRA M MORRONE G BREGNI M SIENA S GIANNI AM VENUTA S
Citation: P. Tassone et al., UN3, A NOVEL MONOCLONAL-ANTIBODY TO HUMAN BONE-MARROW CD34+ HEMATOPOIETIC PROGENITORS, Experimental hematology, 22(8), 1994, pp. 785-785
CHARACTERIZATION AND QUANTITATION OF PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS PRESENT IN PERIPHERAL-BLOOD AUTOGRAFTS
Authors: TONG J HOFFMAN R SIENA S SROUR EF BREGNI M GIANNI AM
Citation: J. Tong et al., CHARACTERIZATION AND QUANTITATION OF PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS PRESENT IN PERIPHERAL-BLOOD AUTOGRAFTS, Experimental hematology, 22(10), 1994, pp. 1016-1024
LARGE-SCALE ENRICHMENT OF MOBILIZED CD34(-BLOOD HEMATOPOIETIC PROGENITORS BY REMOVAL OF NYLON WOOL ADHERENT MATURE CELLS() PERIPHERAL)
Authors: NICOLA MD SIENA S BREGNI M RAVAGNANI F VITELLO F BELLI N DODERO A MAGNI M BONADONNA G GIANNI AM
Citation: Md. Nicola et al., LARGE-SCALE ENRICHMENT OF MOBILIZED CD34(-BLOOD HEMATOPOIETIC PROGENITORS BY REMOVAL OF NYLON WOOL ADHERENT MATURE CELLS() PERIPHERAL), Bone marrow transplantation, 14(6), 1994, pp. 863-869
KINETICS AND RATE OF DECLINE OF PRIMITIVE HEMATOPOIETIC FUNCTIONS AMONG EX-VIVO EXPANDED PROGENITOR CELLS ARE DIFFERENT BETWEEN BONE-MARROWCORD-BLOOD AND MOBILIZED PERIPHERAL-BLOOD CD34+ CELLS
Authors: TRAYCOFF CM SIENA S BREGNI M GIANNI AM SROUR EF
Citation: Cm. Traycoff et al., KINETICS AND RATE OF DECLINE OF PRIMITIVE HEMATOPOIETIC FUNCTIONS AMONG EX-VIVO EXPANDED PROGENITOR CELLS ARE DIFFERENT BETWEEN BONE-MARROWCORD-BLOOD AND MOBILIZED PERIPHERAL-BLOOD CD34+ CELLS, Blood, 84(10), 1994, pp. 10000271-10000271
GENE-THERAPY FOR DRUG-INDUCED MYELOTOXICITY - INDUCTION OF CYCLOPHOSPHAMIDE RESISTANCE BY ALDEHYDE DEHYDROGENASE-1 GENE-TRANSFER
Authors: MAGNI M SHAMMAH S SCHIRO R BREGNI M SIENA S DINICOLA M DALLAFAVERA R GIANNI AM
Citation: M. Magni et al., GENE-THERAPY FOR DRUG-INDUCED MYELOTOXICITY - INDUCTION OF CYCLOPHOSPHAMIDE RESISTANCE BY ALDEHYDE DEHYDROGENASE-1 GENE-TRANSFER, Blood, 84(10), 1994, pp. 10000357-10000357
CLINICAL IMPLICATIONS OF THE HETEROGENEITY OF HEMATOPOIETIC PROGENITORS ELICITED IN PERIPHERAL-BLOOD BY ANTICANCER THERAPY WITH CYCLOPHAMIDE AND CYTOKINE(S)
Authors: SIENA S BREGNI M BONSI L STRIPPOLI P PECCATORI F MAGNI M DINICOLA M BAGNARA GP GIANNI AM
Citation: S. Siena et al., CLINICAL IMPLICATIONS OF THE HETEROGENEITY OF HEMATOPOIETIC PROGENITORS ELICITED IN PERIPHERAL-BLOOD BY ANTICANCER THERAPY WITH CYCLOPHAMIDE AND CYTOKINE(S), Stem cells, 11, 1993, pp. 72-75
RECOMBINANT HUMAN INTERLEUKIN-3 HASTENS TRILINEAGE HEMATOPOIETIC RECOVERY FOLLOWING HIGH-DOSE (7 G M(2)) CYCLOPHOSPHAMIDE CANCER-THERAPY/
Authors: GIANNI AM SIENA S BREGNI M DINICOLA M PECCATORI F MAGNI M RAVAGNANI F SKLENAR I BONADONNA G
Citation: Am. Gianni et al., RECOMBINANT HUMAN INTERLEUKIN-3 HASTENS TRILINEAGE HEMATOPOIETIC RECOVERY FOLLOWING HIGH-DOSE (7 G M(2)) CYCLOPHOSPHAMIDE CANCER-THERAPY/, Annals of oncology, 4(9), 1993, pp. 759-766
HIGH-DOSE SEQUENTIAL CHEMORADIOTHERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - A 6-YEARUPDATE
Authors: GIANNI AM SIENA S BREGNI M LOMBARDI F GANDOLA L DINICOLA M MAGNI M PECCATORI F VALAGUSSA P BONADONNA G
Citation: Am. Gianni et al., HIGH-DOSE SEQUENTIAL CHEMORADIOTHERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - A 6-YEARUPDATE, Annals of oncology, 4(10), 1993, pp. 889-891
GENE-TRANSFER INTO PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITORS FROM CANCER-PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND GROWTH FACTOR(S)
Authors: BREGNI M MAGNI M SIENA S DINICOLA M PECCATORI F RAVAGNANI F BONADONNA G GIANNI AM
Citation: M. Bregni et al., GENE-TRANSFER INTO PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITORS FROM CANCER-PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND GROWTH FACTOR(S), Journal of cellular biochemistry, 1993, pp. 229-229
CLINICAL-APPLICATION OF GROWTH-FACTORS FOR COLLECTION OF CIRCULATING HEMATOPOIETIC PROGENITORS IN BREAST-CANCER PATIENTS TREATED WITH HIGH-DOSE CYCLOPHOSPHAMIDE
Authors: RAVAGNANI F NOTTI P SIENA S BREGNI M ZORZINO L DINICOLA M BELLI N GIANNI AM PELLEGRIS G
Citation: F. Ravagnani et al., CLINICAL-APPLICATION OF GROWTH-FACTORS FOR COLLECTION OF CIRCULATING HEMATOPOIETIC PROGENITORS IN BREAST-CANCER PATIENTS TREATED WITH HIGH-DOSE CYCLOPHOSPHAMIDE, International journal of artificial organs, 16, 1993, pp. 35-38
QUANTIZATION OF CD34-BLOOD HEMATOPOIETIC PROGENITORS FOR AUTOGRAFTINGIN CANCER-PATIENTS( PERIPHERAL)
Authors: DINICOLA M SIENA S BREGNI M PECCATORI F MAGNI M RAVAGNANI F ZORZINO L BONADONNA G GIANNI AM
Citation: M. Dinicola et al., QUANTIZATION OF CD34-BLOOD HEMATOPOIETIC PROGENITORS FOR AUTOGRAFTINGIN CANCER-PATIENTS( PERIPHERAL), International journal of artificial organs, 16, 1993, pp. 80-82
EXAMINATION OF THE HEMATOPOIETIC PROGENITOR-CELL AND STEM-CELL CONTENT OF HUMAN PERIPHERAL-BLOOD AUTOGRAFTS MOBILIZED WITH HIGH-DOSE CYCLOPHOSPHAMIDE FOLLOWED BY GROWTH-FACTOR COMBINATIONS
Authors: HOFFMAN R TONG J SIENA S SROUR EF BREGNI M GIANNI AM
Citation: R. Hoffman et al., EXAMINATION OF THE HEMATOPOIETIC PROGENITOR-CELL AND STEM-CELL CONTENT OF HUMAN PERIPHERAL-BLOOD AUTOGRAFTS MOBILIZED WITH HIGH-DOSE CYCLOPHOSPHAMIDE FOLLOWED BY GROWTH-FACTOR COMBINATIONS, Experimental hematology, 21(8), 1993, pp. 1149-1149
NUMBERS OF HUMAN CD34(-BLOOD WITH HIGH-DOSE CYCLOPHOSPHAMIDE AND RECOMBINANT CYTOKINES INCREASE IN-VITRO FOLLOWING A SHORT EXPOSURE TO STEM-CELL FACTOR() HEMATOPOIETIC PROGENITOR CELLS MOBILIZED INTO PERIPHERAL)
Authors: SROUR EF TONG J EDER P BREGNI M SIENA S GIANNI AM HOFFMAN R
Citation: Ef. Srour et al., NUMBERS OF HUMAN CD34(-BLOOD WITH HIGH-DOSE CYCLOPHOSPHAMIDE AND RECOMBINANT CYTOKINES INCREASE IN-VITRO FOLLOWING A SHORT EXPOSURE TO STEM-CELL FACTOR() HEMATOPOIETIC PROGENITOR CELLS MOBILIZED INTO PERIPHERAL), Experimental hematology, 21(8), 1993, pp. 1184-1184
ESTIMATION OF PERIPHERAL-BLOOD CD34(-PATIENTS() CELLS FOR AUTOLOGOUS TRANSPLANTATION IN CANCER)
Authors: SIENA S BREGNI M GIANNI AM
Citation: S. Siena et al., ESTIMATION OF PERIPHERAL-BLOOD CD34(-PATIENTS() CELLS FOR AUTOLOGOUS TRANSPLANTATION IN CANCER), Experimental hematology, 21(2), 1993, pp. 203-204
INCREASE IN PERIPHERAL-BLOOD MEGAKARYOCYTE PROGENITORS FOLLOWING CANCER-THERAPY WITH HIGH-DOSE CYCLOPHOSPHAMIDE AND HEMATOPOIETIC GROWTH-FACTORS
Authors: SIENA S BREGNI M BONSI L SKLENAR I BAGNARA GP BONADONNA G GIANNI AM
Citation: S. Siena et al., INCREASE IN PERIPHERAL-BLOOD MEGAKARYOCYTE PROGENITORS FOLLOWING CANCER-THERAPY WITH HIGH-DOSE CYCLOPHOSPHAMIDE AND HEMATOPOIETIC GROWTH-FACTORS, Experimental hematology, 21(12), 1993, pp. 1583-1590
ROLE OF CHEMOTHERAPY AND GM-CSF ON HEMATOPOIETIC PROGENITOR-CELL MOBILIZATION IN MULTIPLE-MYELOMA
Authors: TARELLA C BOCCADORO M OMEDE P BONDESAN P CARACCIOLO D FRIERI R BREGNI M SIENA S GIANNI AM PILERI A
Citation: C. Tarella et al., ROLE OF CHEMOTHERAPY AND GM-CSF ON HEMATOPOIETIC PROGENITOR-CELL MOBILIZATION IN MULTIPLE-MYELOMA, Bone marrow transplantation, 11(4), 1993, pp. 271-277
RHGM-CSF OR RHG-CSF TO ENHANCE CIRCULATION OF HEMATOPOIETIC PROGENITORS AND TO AMELIORATE THE HEMATOLOGIC TOXICITY OF HIGH-DOSE CYCLOPHOSPHAMIDE (HD-CTX) CANCER-THERAPY
Authors: BREGNI M SIENA S DINICOLA M MAGNI M PECCATORI F RAVAGNANI F BONADONNA G GIANNI AM
Citation: M. Bregni et al., RHGM-CSF OR RHG-CSF TO ENHANCE CIRCULATION OF HEMATOPOIETIC PROGENITORS AND TO AMELIORATE THE HEMATOLOGIC TOXICITY OF HIGH-DOSE CYCLOPHOSPHAMIDE (HD-CTX) CANCER-THERAPY, Blood, 82(10), 1993, pp. 10000495-10000495
Risultati: 1-25 | 26-49 |